New drug combo tested for Tough-to-Treat liver cancer
Disease control
Not yet recruiting
This study is testing if adding an experimental drug called GKL-006 to a standard liver cancer treatment (TACE) is more effective and safe. It will involve about 48 adults with advanced liver cancer that cannot be removed by surgery. The main goal is to see if the combination shr…
Phase: PHASE2 • Sponsor: Beijing Gene Key Life Technology Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC